(Q48539825)

English

Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.

scientific article published in December 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

2

object named as

Rinne JO

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

8

object named as

Rinne UK

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

author name string

Ruottinen HM

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Bergman JR

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Haaparanta MT

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Solin OH

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Ruotsalainen UH

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

27

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

336-346

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

18 FFluoro-dopa, an analogue of dopa, and its use in direct external measurements of storage, degradation, and turnover of intracerebral dopamine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Dopa decarboxylase activity of the living human brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

3-O-methyldopa administration does not alter fluorodopa transport into the brain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

The metabolism of L-3-0-methyldopa, aprecursor of dopa in man

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Similarity in the aldehyde oxidases from guinea-pig liver and polymorphonuclear leucocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199712%2927%3A4%3C336%3A%3AAID-SYN7%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/(SICI)1098-2396(199712)27:4<336::AID-SYN7>3.0.CO;2-D

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9372556

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48539825&oldid=2152637643"